Authors: Ozaki, K Enomoto, T Yoshino, K Fujita, M Buzard, GS Kawano, K Yamasaki, M Murata, Y

Citation: K. Ozaki et al., Impaired FHIT expression characterizes serous ovarian carcinoma, BR J CANC, 85(2), 2001, pp. 247-254

Authors: Srikantan, V Zou, ZQ Petrovics, G Xu, L Augustus, M Davis, L Livezey, JK Connell, T Sesterhenn, IA Yoshino, K Buzard, GS Mostofi, FK McLeod, DG Moul, JW Srivastava, S

Citation: V. Srikantan et al., PCGEM1, a prostate-specific gene, is overexpressed in prostate cancer, P NAS US, 97(22), 2000, pp. 12216-12221

Authors: Buzard, GS Enomoto, T Anderson, LM Perantoni, AO Devor, DE Rice, JM

Citation: Gs. Buzard et al., Activation of neu by missense point mutation in the transmembrane domain in schwannomas induced in C3H/HeNCr mice by transplacental exposure to N-nitrosoethylurea, J CANC RES, 125(12), 1999, pp. 653-659

Authors: Buzard, GS Enomoto, T Hongyo, T Perantoni, AO Diwan, BA Devor, DE Reed, CD Dove, LF Rice, JM

Citation: Gs. Buzard et al., neu mutation in schwannomas induced transplacentally in Syrian golden hamsters by N-nitrosoethylurea: high incidence but low allelic representation, J CANC RES, 125(10), 1999, pp. 529-540

Authors: Shiao, YH Palli, D Buzard, GS Caporaso, NE Amorosi, A Saieva, C Fraumeni, JF Anderson, LM Rice, JM

Citation: Yh. Shiao et al., Implications of p53 mutation spectrum for cancer etiology in gastric cancers of various histologic types from a high-risk area of central Italy, CARCINOGENE, 19(12), 1998, pp. 2145-2149